Governance strategies for biological AI: beyond the dual-use dilemma
Trends in Biotechnology · 2025
DOI: 10.1016/j.tibtech.2025.09.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2025. Verfasst von Alex B Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Metabolism Unit, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Biological Science Disciplines. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
A common framing for governing artificial intelligence (AI) in the biological sciences is to focus on risk mitigation owing to the technology's potential 'dual-use' for both beneficial and harmful applications. This is a reactive policy approach, and a broader framing that urges policymakers to actively champion the benefits alongside mitigating risks is needed, including through targeted investments aimed at securing public priorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Metabolism Unit, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: aclewis@bwh.harvard.edu.
Zitieren
APA
Lu, A. B., & Lewis, A. C. F. (2025). Governance strategies for biological AI: beyond the dual-use dilemma. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2025.09.012
Vancouver
Lu AB, Lewis ACF. Governance strategies for biological AI: beyond the dual-use dilemma. Trends in Biotechnology. 2025. doi:10.1016/j.tibtech.2025.09.012
BibTeX
@article{Lu2025,
author = {Lu, Alex B and Lewis, Anna C F},
title = {Governance strategies for biological AI: beyond the dual-use dilemma},
journal = {Trends in Biotechnology},
year = {2025},
doi = {10.1016/j.tibtech.2025.09.012}
}
EUVIMED